Sponsor or institution
Clinical trials and research at Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) that are recruiting, in United States. By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
18F-mFBG PET imaging of heart nerve uptake in Lewy body dementia and Parkinson disease.
This study will test whether the PET tracer 18F-mFBG can measure loss of heart sympathetic nerve function in people with Lewy body dementia or Parkinson disease.
-
18F-mFBG imaging to map heart nerve signals in people with ischemic heart failure and ICDs
Researchers are testing whether 18F-mFBG PET imaging can see heart nerve activity in people with ischemic heart failure and an ICD.
Quick answers
How many clinical trials run by Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.